Search results
Results From The WOW.Com Content Network
Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. History. Alcon was founded in 1945 as a small pharmacy in Fort Worth, Texas, United States.
Alcon, which started in Fort Worth and has grown to become the world’s largest eye care device company, is looking to invest an estimated $100 million to build a 250,000-square-foot ...
8.25% [5] Website. celina-tx.gov. Celina ( / sɪˈlaɪnə / sil-EYE-nə) is a city in Collin and Denton counties in the U.S. state of Texas. Celina is part of the Dallas–Fort Worth metroplex . The population was 16,739 at the 2020 census, [3] and according to 2023 census estimates, the city is estimated to have a population of 43,317.
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
Website. www .actavis .com. Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Area codes. 682, 817, 940. Website. alliancetexas .com. Alliance is a planned community located within Denton County and Tarrant County, Texas, United States. It includes parts of the cities of Haslet, Fort Worth, Westlake, Northlake, Denton, and Roanoke. It is currently owned by Hillwood, a Henry Ross Perot, Jr. company.
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...